FACTANKER · measured, cited, anchored official records connected

SEC EDGAR CompanyFacts fact · point in time

IMMUNE PHARMACEUTICALS INC: cash_and_equivalents

One fact, its scope and the complete path back to the official record.

Period: as of 2011-03-31Status: currentProvenance attached

Cite: FACTANKER, https://factanker.com/fact/db638f93-ad75-4b97-ab75-ff08c4eb948a

Reported value

$10.212M{"amount": 10212000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"}
Entity
IMMUNE PHARMACEUTICALS INC
Metric
cash_and_equivalents
Period
as of 2011-03-31
Status
current
Source
SEC EDGAR CompanyFacts

Provenance

Official reference0001104659-12-035761 · Open the official SEC filing →
Source licenseUS-PD-17USC105
Retrieved2026-08-19T11:55:41.451672+02:00
Raw response SHA-256f7bde1a401b286c74a2fd824ee1df541…
Official-identifier pathhttps://factanker.com/fact/sec/cik-0001208261/cash-and-equivalents/2011-03-31 (CIK, metric, reporting date)
History
  • no predecessors — first report

Why this page exists

The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.